Back
Editas Medicine 10K Form
Buy
55
EDIT
Editas Medicine
Last Price:
5.76
Seasonality Move:
18.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EDIT News And Ratings
See the #1 stock for the next 7 days that we like better than EDIT
EDIT Financial Statistics
Sales & Book Value
| Annual Sales: | $78.12M |
|---|---|
| Cash Flow: | $-51.74M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.58 |
| Price / Book: | 1.51 |
Profitability
| EPS (TTM): | -2.10000 |
|---|---|
| Net Income (TTM): | $-166.13M |
| Gross Margin: | -- |
| Return on Equity: | -48.26% |
| Return on Assets: | -33.9% |
Editas Medicine Earnings Forecast
Key Editas Medicine Financial Ratios
- The Research & Development expenses have been 227.40% of Revenue.
- The Interest Expense is 5.47% of Operating Income.
- The Net Earning history of EDIT is -196.13% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Editas Medicine Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EDIT |
| CUSIP: | 28106W |
| Website: | editasmedicine.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.6 |
| Quick Ratio: | 4.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EDIT Technical Analysis vs Fundamental Analysis
Buy
55
Editas Medicine (EDIT)
is a Buy
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Buy
The current Editas Medicine [EDIT] share price is $5.41. The Score for EDIT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.